Module 12: MSK (a) Flashcards
1
Q
MSK Drugs
-Chronic Pain Tx Goal?
A
- Lessening the progression
2. Improving Function
2
Q
Pain Overview
-Nociceptive
A
- Adaptive (Protective) pain — sensed by pain receptors
- Somatic pain — MSK pain; Visceral pain - pain from organs Ex: bruise, burn, cut, fracture — May feel sharp, dull, throbbing, aching
3
Q
Pain Overview
-Inflammatory
A
- Adaptive (protective) pain — Results from local inflammation (Ex: Arthritis, infection, tissue injury)
—Some consider inflammatory pain a subcategory of nociceptive pain — May throb or ache
4
Q
Pain Overview
-Pathologic - Neuropathic & Central Pain
A
- Maladaptive pain — Damage or dysfunction of nervous system (Ex: DM, nerve injury, central pain disorders)
- Pain may be described as pain hypersensitivity “Nociplastic pain”
- Examples — Neuropathic pain, diabetic neuropathy central, nociplastic pain, fibromyalgia - Might feel electric, burning, pins and needles, tingling, shooting
5
Q
Pain Management Options For:
-Nociceptive Pain?
A
- NSAIDs
- Acetaminophen
- Muscle relaxants (For muscle spasm r/t pain — Cyclobenzaprine, tizanidine, baclofen
6
Q
Pain Management Options For:
-Inflammatory Pain
A
- NSAIDs (Ex: Ibuprofen, naproxen, Meloxicam, ketorolac, diclofenac topical gel
- Systemic steroid (Oral, IM, Intra-articular)
7
Q
Pain Management Options For:
-Neuropathic & Central Pain
A
Evidence for the following meds efficacy is mixed and limited
- Anticonvulsants (Gabapentin, Pregabalin)
- SNRIs (Duloxetine, milnacipran)
- TCAs (amitriptyline)
- Topical agents? (Lidocaine or capsaicin)
8
Q
NSAIDs
-Info
A
- Ibuprofen, Naproxen — Short-to-moderate acting & commonly used
- Meloxicam — LONG duration of effect — Slow onset
- Celecoxib — SELECTIVE COX-2 inhibitor w/ reduced risk of GI toxicity compared to nonselective NSAIDs
- Indomethacin — Most commonly considered w/ GOUT
9
Q
Acute Moderate-Severe Back Pain
-Treatment Options
A
- Initial therapy — NSAID 2-4 weeks
- For Severe pain:
- Ketorolac <5 days
- Tramadol <2 weeks
- Opiate 3-7 days
10
Q
NSAIDs
-A/Es
A
- Increased risk of GI bleeding
- When used long term, consider gastro-prophylaxis such as a PPI
- NSAIDs can cause or worsen renal impairment —AVOID in patients with CrCl < 60. Routinely monitor serum creatinine w/ dose changes
- CV disease and those at risk for CV disease — Nonselective NSAIDs reversible inhibit PLT functioning and cardio protective effects of ASA
- Take ASA and NSAIDs at least 2 hrs apart - NSAIDs can increase BP by diminishing efficacy of anti-HTN meds — Avoid NSAIDs in pt’s with difficult to control HTN
11
Q
NSAIDs
-Ketorolac
A
- Alt to narcotic analgesic — Used for moderately severe acute pain — DO NOT use longer than 5 days — IM injection
- DO NOT add to another NSAID
- MULTIPLE BBW — GI, CV, Renal, Bleeding/Labor & delivery risks, hypersensitivity reaction — including ASA or NSAID reactions
12
Q
Acetaminophen/Paracetamol
A
- First-line tx option in mgmt of mild persistent pain
- Lacks significant anti-inflammatory properties — Less effective for inflammatory pain than NSAIDS
- Can cause hepatotoxicity w/ chronic use
- Max dose is less than 3-4 grams in 24 hrs — Less than 2 grams in frail Pt’s and those >80 yrs
- For severe cases use an NSAID + Acetaminophen — Resembles an opioid
13
Q
Muscle Relaxants
A
- May provide analgesia and a degree of skeletal muscle relaxation or relief from muscle spasms
- A/Es include — Sedation, dizziness r/t CNS and Anticholinergic activity — Watch in older patients
- Educate Pt’s on impairment and sedation — Might take at bedtime d/t sedation
14
Q
Muscle relaxants
-Example Meds
A
- Cyclobenzaprine (Flexeril) — First line medication
- Methocarbamol (Robaxin)
- Carisoprodol (Soma) — Concerns for abuse — Controlled
Can cause Sedation
15
Q
Tramadol (Ultramar)
A
- Opiate analgesic (Codeine analog) w/ weak mu-receptor binding
- Potential risk of serotonin syndrome when combine w/ other SSRIs
- Option for severe or refractory pain — Short-term <2 wks (Schedule IV)
- Avoid in children, pregnancy/lactation